Development and Characterization of Clinical-Grade Zr-89-Trastuzumab for HER2/neu ImmunoPET Imaging

E.C.F. Dijkers, J.G.W. Kosterink, A.C.H.J. Rademaker, L.R. Perk, G.A.M.S. van Dongen, J. Bart, J.R. de Jong, E.G. de Vries, M.N. Lub-de Hooge

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)974-981
JournalJournal of Nuclear Medicine
Volume50
Issue number6
DOIs
Publication statusPublished - 2009

Cite this

Dijkers, E. C. F., Kosterink, J. G. W., Rademaker, A. C. H. J., Perk, L. R., van Dongen, G. A. M. S., Bart, J., ... Lub-de Hooge, M. N. (2009). Development and Characterization of Clinical-Grade Zr-89-Trastuzumab for HER2/neu ImmunoPET Imaging. Journal of Nuclear Medicine, 50(6), 974-981. https://doi.org/10.2967/jnumed.108.060392